4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-027121
Chief Medical Officer sold 2,000 shares at $44.50 ($89,000)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2021-04-14 | Option exercise | +2,000 | $7.80 | $15,600 | 24,894 | D: show line 1 in the form |
| BALDO LANCE Chief Medical Officer | 2021-04-14 | Sale | −2,000 | $44.50 | $89,000 | 22,894 | D: show line 2 in the form |
| Open-market sales · 2,000 sh · avg $44.50 · $89,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2021-04-14 | Option exercise · Stock Option (Right to Buy) | −2,000 | 339,250 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…